DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kowdley KV, Lawitz E, Crespo I et al.
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
Lancet 2013;
381: 2100-2107
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.